MEHTA, P.; THUMMAR, V.; BHAVSAR, H. Clinical outcomes of neoadjuvant dual HER2 blockade with pertuzumab/Sigrima and trastuzumab/Vivitra biosimilars: real-world evidence in HER2-positive breast cancer in India. International Journal of Research in Medical Sciences, [S. l.], v. 14, n. 4, p. 1584–1588, 2026. DOI: 10.18203/2320-6012.ijrms20260973. Disponível em: https://www.msjonline.org/index.php/ijrms/article/view/16637. Acesso em: 7 apr. 2026.